L

Laurus Labs Ltd

PharmaceuticalsLargecap

About the company

Laurus Labs Private Ltd is a research and development pharmaceutical company which manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Performance

Stock
Loading Stock value
—

Analyst Ratings and Key Metrics

Based on 13 analysts offering recommendations for Laurus Labs Ltd

62%

Buy

23%

Hold

15%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio140.1945.37
PB Ratio22.946.07
Dividend Yield0.09%0.47%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions